Matthew J. Koster

3.3k total citations
128 papers, 1.5k citations indexed

About

Matthew J. Koster is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, Matthew J. Koster has authored 128 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Pulmonary and Respiratory Medicine, 66 papers in Rheumatology and 31 papers in Genetics. Recurrent topics in Matthew J. Koster's work include Vasculitis and related conditions (67 papers), Otitis Media and Relapsing Polychondritis (37 papers) and Histiocytic Disorders and Treatments (20 papers). Matthew J. Koster is often cited by papers focused on Vasculitis and related conditions (67 papers), Otitis Media and Relapsing Polychondritis (37 papers) and Histiocytic Disorders and Treatments (20 papers). Matthew J. Koster collaborates with scholars based in United States, Italy and Thailand. Matthew J. Koster's co-authors include Kenneth J. Warrington, Eric L. Matteson, Cynthia S. Crowson, Patompong Ungprasert, Ashima Makol, Steven R. Ytterberg, Ronald S. Go, Cornelia M. Weyand, Mithun Vinod Shah and Gaurav Goyal and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Matthew J. Koster

111 papers receiving 1.4k citations

Peers

Matthew J. Koster
E. L. Matteson United States
Lorna Neill United Kingdom
Karina A. Keogh United States
R. Valente United States
Matthew J. Koster
Citations per year, relative to Matthew J. Koster Matthew J. Koster (= 1×) peers Hubert de Boysson

Countries citing papers authored by Matthew J. Koster

Since Specialization
Citations

This map shows the geographic impact of Matthew J. Koster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Koster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Koster more than expected).

Fields of papers citing papers by Matthew J. Koster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Koster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Koster. The network helps show where Matthew J. Koster may publish in the future.

Co-authorship network of co-authors of Matthew J. Koster

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Koster. A scholar is included among the top collaborators of Matthew J. Koster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Koster. Matthew J. Koster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weeks, Lachelle D., Danielle Hammond, Sinisa Savic, et al.. (2025). Establishing a consensus definition of VEXAS flare for clinical research. Lara D. Veeken. 65(2).
2.
Koster, Matthew J., et al.. (2025). Novel Photon-Counting Computed Tomography for the Evaluation of Large-Vessel Giant Cell Arteritis. The Journal of Rheumatology. 52(8). 842–843.
3.
Bowen, Andrew J., Hawa M. Ali, Eric S. Edell, et al.. (2025). Surgical Recurrence Across Endoscopic Surgical Techniques in Idiopathic Subglottic Stenosis. The Laryngoscope. 135(9). 3280–3286.
4.
Abeykoon, Jithma P., Saurabh Zanwar, Gordon Ruan, et al.. (2025). Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants. Leukemia. 39(4). 991–994. 3 indexed citations
5.
Crowson, Cynthia S., et al.. (2025). Population-Based Performance of Inflammatory Markers in Giant Cell Arteritis. American Journal of Ophthalmology. 275. 47–51.
6.
Bowen, Andrew J., Hawa M. Ali, David O. Francis, et al.. (2025). Surgical Management of Idiopathic Subglottic Stenosis During Pregnancy: A Multi‐Institutional Study. The Laryngoscope. 135(12). 4767–4773.
7.
Eshak, Nouran, Felipe Martinez, Carolyn Mead‐Harvey, et al.. (2025). Role of F-18 FDG-PET CT scan in the evaluation of medium vessel vasculitis. Seminars in Arthritis and Rheumatism. 75. 152864–152864.
8.
Bowen, Andrew J., Hawa M. Ali, Thomas J. O’Byrne, et al.. (2024). Age and Menopausal Status in Idiopathic Subglottic Stenosis. The Laryngoscope. 135(1). 198–205. 4 indexed citations
9.
Berry, Gerald J., Andrew C. Hanson, Cynthia S. Crowson, et al.. (2024). Subclinical aortic inflammation in patients with polymyalgia rheumatica. Lara D. Veeken. 63(12). 3289–3296. 3 indexed citations
10.
Ghaffar, Umar, et al.. (2023). Clinical Images: Tongue ulceration in giant cell arteritis associated with asymptomatic retinal ischemia. ACR Open Rheumatology. 5(7). 331–331.
11.
Crowson, Cynthia S., et al.. (2023). The epidemiology of pathologically confirmed clinically isolated aortitis: a North American population-based study. Clinical and Experimental Rheumatology. 41(4). 956–960. 7 indexed citations
12.
Goyal, Gaurav, Jithma P. Abeykoon, Chen Dai, et al.. (2023). Long-term outcomes among adults with Langerhans cell histiocytosis. Blood Advances. 7(21). 6568–6578. 10 indexed citations
13.
Koster, Matthew J., Terra L. Lasho, Horatiu Olteanu, et al.. (2023). VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management. American Journal of Hematology. 99(2). 284–299. 28 indexed citations
14.
Koster, Matthew J., et al.. (2023). Clinical Images: IgG4‐related disease: a giant cell arteritis mimic. Arthritis & Rheumatology. 75(7). 1262–1262. 2 indexed citations
15.
Espitia, Olivier, Melanie C. Bois, Matthew J. Koster, et al.. (2022). Relationship between histopathological features of non-infectious aortitis and the results of pre-operative 18F-FDG-PET/CT: a retrospective study of 16 patients. Clinical and Experimental Rheumatology. 41(4). 916–921. 5 indexed citations
16.
Banks, Samantha A., M. Tariq Bhatti, Ronald S. Go, et al.. (2022). Ophthalmologic Involvement in Adults with Histiocytic Disorders. Ophthalmology. 130(1). 77–86. 2 indexed citations
17.
Hazim, Antonious, Gordon Ruan, Marie Hu, et al.. (2021). Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival. American Journal of Hematology. 96(12). 1604–1610. 10 indexed citations
18.
Abeykoon, Jithma P., Aishwarya Ravindran, Karen L. Rech, et al.. (2021). Mimics of Erdheim–Chester disease. British Journal of Haematology. 196(4). 984–994. 3 indexed citations
19.
Richter, Michael, Cynthia S. Crowson, Matthew J. Koster, et al.. (2019). Rituximab Therapy for Systemic Rheumatoid Vasculitis: Indications, Outcomes, and Adverse Events. The Journal of Rheumatology. 47(4). 518–523. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026